Table 2 Recoil retention of 213Bi in the tumour tissue at 1 and 7 days after intratumoural injection of 225Ac encapsulated in polymersomes with a diameter of either 100 nm or 200 nm.

From: The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier

Organ 1 day p.i.

Blood

Tumour

Kidney

100 nm

200 nm

100 nm

200 nm

100 nm

200 nm

\({A}_{{213}_{Bi}}(t=0)\) (% ID/g)

1.2 ± 0.1

1.5 ± 1.4

122 ± 57

318 ± 111

23.0 ± 5.4

17 ± 7

\({A}_{{213}_{Bi}}(t=eq)\) (% ID/g)

0.05 ± 0.01

0.02 ± 0.01

212 ± 100

386 ± 154

0.87 ± 0.09

0.8 ± 0.4

Ratio

26 ± 8

58 ± 34

0.58 ± 0.06

0.87 ± 0.04

26 ± 6

23 ± 5

7 days p.i.

100nm

200nm

100nm

200nm

100nm

200nm

\({A}_{{213}_{Bi}}(t=0)\) (% ID/g)

0.9 ± 0.4

1.8 ± 0.9

146 ± 96

285 ± 75

15 ± 6

9 ± 4

\({A}_{{213}_{Bi}}(t=eq)\) (% ID/g)

0.01 ± 0.01

0.3 ± 0.4

269 ± 224

320 ± 116

0.9 ± 0.5

0.8 ± 0.5

Ratio

70 ± 40

30 ± 36

0.59 ± 0.12

0.91 ± 0.10

19 ± 10

12 ± 5

  1. The numbers represent the ratio of the \({A}_{{213}_{Bi}}(t)\), the 213Bi activity at time t = 0 of sacrifice, to 225Ac (t = eq), the 213Bi activity in equilibrium with 225Ac, calculated as \(Ratio={A}_{{213}_{Bi}}(t=0)/{A}_{{213}_{Bi}}(t=eq)\). The uncertainty corresponds to standard deviations based on three mice per polymersome diameter and time point.